|Age:||18 years or older|
|Keywords:||Refractory Acute Myeloid Leukemia, relapsed Acute Myeloid Leukemia, Acute Myeloid Leukemia, blood cancer|
|Type:||Drug study, Phase 1|
The study team will make sure you qualify to take part in the study. Qualified participants will receive detailed information about the study. This may include a list of study-related tests and procedures.